Find a Specialist by Postal Code | Page 5 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Amir Fathi, MD Massachusetts General Hospital Boston Massachusetts United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Roni Tamari, MD Memorial Sloan-Kettering Cancer Center New York City New York United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Steven Gore, M.D. Yale New Haven Hospital New Haven Connecticut United States
  • Myelodysplastic Syndromes (MDS)
Mina L. Xu, MD Yale University School of Medicine New Haven Connecticut United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Firas El Chaer, MD University of Virginia Charlottesville Virginia United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Seth Rotz, MD Cleveland Clinic Children's Hospital Cleveland Ohio United States
  • Pediatric
Mojtaba Akhtari, MD Loma Linda University Cancer Center Loma Linda California United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Lucy Godley, MD, PhD University of Chicago Duchossois Center for Advanced Medicine - Hyde Park Chicago Illinois United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alison R. Walker, MD H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida Tampa Florida United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Christopher Cogle, MD University of Florida Health Cancer Center Gainesville Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Shyam Ajay Patel, MD, PhD UMass Chan Medical School Worcester Massachusetts United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
David Beck, MD, PhD NYU Grossman School of Medicine New York New York United States
Aditi Shastri, M.B.B.S. Albert Einstein College of Medicine Bronx New York United States
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
Rabi Hanna, MD The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Pediatric
Marcin Wlodarski, MD, PhD St Jude Children’s Research Hospital Memphis Tennessee United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
David Steensma, MD, FACP Dana-Farber Cancer Institute Boston Massachusetts United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Laura Michaelis, MD, ABIM Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Neal Young, MD National Heart, Lung, and Blood Institute - National Institutes of Health Bethesda Maryland United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Jaap Jan Boelens, M.D. Memorial Sloan Kettering Cancer Center New York New York United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Pediatric
Robert Hasserjian, MD Massachusetts General Hospital Boston Massachusetts United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)